A detailed history of Jane Street Group, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 62,354 shares of VIGL stock, worth $207,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,354
Holding current value
$207,638
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.51 - $4.66 $156,508 - $290,569
62,354 New
62,354 $249,000
Q4 2023

Feb 14, 2024

BUY
$2.97 - $8.6 $30,228 - $87,530
10,178 New
10,178 $34,000
Q1 2023

May 15, 2023

BUY
$8.77 - $12.7 $238,403 - $345,236
27,184 New
27,184 $266,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $94.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.